Literature DB >> 17182338

Oral miltefosine to treat new world cutaneous leishmaniasis.

Jaime Soto, Julia T Toledo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17182338     DOI: 10.1016/S1473-3099(06)70665-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  5 in total

1.  Cutaneous leishmaniasis after travel to Cyprus and successful treatment with miltefosine.

Authors:  Wolfgang Poeppl; Julia Walochnik; Tom Pustelnik; Herbert Auer; Gerhard Mooseder
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

2.  Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.

Authors:  Liliana López; Martha Robayo; Margarita Vargas; Iván D Vélez
Journal:  Trials       Date:  2012-05-17       Impact factor: 2.279

Review 3.  Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance.

Authors:  P M Loiseau; S Cojean; J Schrével
Journal:  Parasite       Date:  2011-05       Impact factor: 3.000

4.  Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.

Authors:  Suzette Kämink; Boota Masih; Noor Ali; Aman Ullah; Syed Juma Khan; Shakil Ashraf; Tetyana Pylypenko; Martin P Grobusch; Jena Fernhout; Margriet den Boer; Koert Ritmeijer
Journal:  PLoS Negl Trop Dis       Date:  2021-01-28

5.  The activity of ozonated olive oil against Leishmania major promastigotes.

Authors:  Omid Rajabi; Ameneh Sazgarnia; Fatemeh Abbasi; Pouran Layegh
Journal:  Iran J Basic Med Sci       Date:  2015-09       Impact factor: 2.699

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.